Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The clinical laboratory services market has been experiencing notable trends and transformations driven by various factors such as technological advancements, demographic changes, and evolving healthcare policies. One significant trend in the clinical laboratory services market is the increasing demand for personalized medicine and molecular diagnostics. With advancements in genomics, proteomics, and other molecular testing techniques, healthcare providers are increasingly utilizing laboratory services to tailor treatment plans to individual patients based on their genetic makeup, biomarker profiles, and disease characteristics. This has led to a growing demand for specialized laboratory tests and assays that enable more accurate diagnosis, prognosis, and therapeutic decision-making across a wide range of medical specialties.
Moreover, there is a rising emphasis on automation and digitalization in clinical laboratory operations to improve efficiency, accuracy, and turnaround times for diagnostic testing. Laboratories are investing in advanced laboratory information management systems (LIMS), robotics, and artificial intelligence (AI) technologies to streamline sample processing, data analysis, and result reporting workflows. This trend towards laboratory automation not only enhances operational efficiency but also reduces human errors, improves quality control, and enables laboratories to handle larger volumes of testing with greater scalability and flexibility.
Additionally, the clinical laboratory services market is witnessing increasing consolidation and integration of laboratory networks to achieve economies of scale, expand service offerings, and improve market competitiveness. Large laboratory chains and integrated healthcare systems are acquiring smaller independent laboratories, forming strategic partnerships, and establishing centralized testing facilities to optimize resource utilization, standardize testing protocols, and enhance service delivery across geographic regions. This consolidation trend is reshaping the competitive landscape of the clinical laboratory services market and driving innovation in service delivery models and value-based care initiatives.
Furthermore, there is a growing demand for point-of-care (POC) testing services and decentralized laboratory solutions to support rapid diagnosis, treatment monitoring, and healthcare delivery in non-traditional settings. POC testing enables healthcare providers to perform diagnostic tests directly at the patient's bedside, in clinics, or even in remote and resource-limited environments, without the need for centralized laboratory facilities. This trend towards decentralization of laboratory services is fueled by advancements in portable diagnostic devices, connectivity technologies, and regulatory initiatives aimed at expanding access to diagnostic testing and improving patient outcomes.
Moreover, the clinical laboratory services market is witnessing a shift towards value-based reimbursement models and outcomes-driven healthcare delivery. With increasing pressure to contain healthcare costs and improve patient outcomes, payers and healthcare providers are incentivizing laboratories to demonstrate the clinical utility and cost-effectiveness of laboratory testing through evidence-based medicine, outcomes research, and performance metrics. This has led to a growing emphasis on population health management, care coordination, and utilization management in clinical laboratory services, as laboratories seek to align their testing strategies with value-based care objectives and demonstrate their contribution to improving patient care outcomes.
Lastly, the clinical laboratory services market is experiencing significant growth in emerging markets, driven by increasing healthcare spending, expanding access to healthcare services, and rising awareness about the importance of diagnostic testing in disease prevention and early detection. Developing countries in Asia, Africa, and Latin America are witnessing rapid economic growth, urbanization, and epidemiological transitions, leading to a growing burden of chronic diseases and infectious diseases. This has created opportunities for laboratory service providers to expand their presence in these markets by offering affordable, high-quality testing services tailored to the needs and preferences of local healthcare systems and patients.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | Untapped emerging economies |
| Market Dynamics | Rising number of advancements of quick & inescapable testing Increasing frequencies of ongoing illnesses |
Clinical Laboratory Services Market Highlights:
Clinical Laboratory Services Market Overview
Clinical Laboratory Services Market Size was valued at USD 252.36 Billion in 2023. The Global Clinical Laboratory Services industry is projected to grow from USD 262.01 Billion in 2024 to USD 355.94 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.90% during the forecast period (2024 - 2032). Rising number of advancements of quick & inescapable testing and increasing frequencies of ongoing illnesses are boosting the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Clinical Laboratory Services Market Trends
- Increasing prevalence of chronic diseases fuels market growth
The rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, Alzheimer’s, obesity, arthritis, and cancer demands clinical diagnostics. Clinical pathology tests are performed on collected clinical specimens at a clinical laboratory to obtain information about the patient’s health and aid in diagnosing, preventing, and treating diseases. Hence, the growing incidence of chronic diseases is anticipated to fuel the market growth during the assessment period. Cancer caused a significant impact on society across the globe. As per the World Health Organization, there were 10 million deaths caused due to the cancer in 2020.
Moreover, early diagnosis of diseases such as cancer, heart disease, respiratory disease, kidney disease, and others can substantially improve the chances of successful treatment. US government and various international organizations have launched several initiatives to raise awareness about early diagnosis. For instance, in 2020, the American Society of Nephrology has launched a new initiative Acute Kidney Injury (AKI) to encourage excellence in the prevention and treatment of AKI by establishing a foundational program that transforms education and AKI care delivery.
Clinical Laboratory Services Market Segment Insights
Clinical Laboratory Services Type Insights
The clinical laboratory services market segmentation, based on type, includes biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, and genetic testing. The biochemistry segment held the majority share in 2021 contribution to around XX% in respect to the clinical laboratory services revenue. This is due to the rising prevalence of heart and renal diseases, the demand for biochemical laboratory testing is also escalating, as biochemical tests are of great importance in the diagnosis of heart diseases.
August 2021: OPKO Health, Inc. (US), a subsidiary of BioReference Laboratories (US), acquired F. Hoffmann-La Roche Ltd. (Switzerland), the US's centralized prenatal laboratory testing business. This helped the company further strengthen its genetic testing service capabilities.
Clinical Laboratory Services Application Insights
The clinical laboratory services market segmentation, based on application, includes independent laboratory, reference laboratory, and hospital laboratory. The hospital laboratory dominated the market in 2021 and independent laboratory is projected to be the faster-growing segment during the forecast period, 2024-2032. Hospitals being a primary center for providing healthcare services have clinical and medical laboratories as their major departments. These laboratories operate in multiple disciplines of chemistry, microbiology, virology, hematology, histology, immunology or molecular diagnostics, and the blood bank. This can be attributed to high test volumes followed by favorable reimbursements. According to the article published in the Journal of the American Medical Association (JAMA) Network in 2021, more than 12 billion clinical laboratory tests are analyzed in the US each year, making them the highest-volume health care service nationwide.
December 2021: Eurofins Scientific (Luxembourg) signed an agreement with Transgenic, Inc. (Japan) to acquire Genetic Lab Co., Ltd. This acquisition further enhanced Eurofin's expansion in Asia-Pacific and complemented clinical diagnostics laboratories across the globe, which are primarily focused on specialized and advanced genetic testing.
Figure 2: Clinical Laboratory Services Market, by Application, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Clinical Laboratory Services Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America clinical laboratory services market is propelling due to the rising incidences of chronic diseases, growing awareness among people regarding disease management and early diagnosis. Moreover, growing popularity of personalized medicine in the US is projected to create lucrative growth opportunities.
Further, the major countries studied are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: CLINICAL LABORATORY SERVICES SHARE BY REGION 2021 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe clinical laboratory services market accounts for the second-largest market share due to a government initiative to increase awareness about preventive screening, improved public and private funding for clinical laboratory test development research, and high adoption of genome-based laboratory tests. Furthermore, the Germany clinical laboratory services market attributed to hold the largest market share, and the France clinical laboratory services market was expected the fastest growing market in the Europe region
The Asia-Pacific clinical laboratory services market is expected to grow at a steady pace from 2024 to 2032. This is owing to the increasing healthcare infrastructure, rising number of hospitals & clinical diagnostic laboratories in China and India. Moreover, China clinical laboratory services market attributed to held the largest market share, and the India clinical laboratory services market was the fastest growing market in the Asia-Pacific region.
Clinical Laboratory Services Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the clinical laboratory services market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the clinical laboratory services industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
Additionally, Laboratory Corporation of America Holdings (US) operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics, and Covance Drug Development. In February 2022, Laboratory Corporation of America Holdings collaborated with Ascension, a US-based Catholic and non-profit health system, to expand its clinical test services. The collaboration aims to administer Ascension's hospital-based laboratories in 10 states, further growing its laboratory services across the US.
Mayo Medical Laboratories (US) offers clinical testing to support health care systems, hospitals, specialty clinics, and other clinical laboratories. It provides scientific testing services for various indications, including cardiology, genetics and pharmacogenomics, drugs of abuse, and hematology. In April 2020, the company introduced serology testing service to identify the immune response to ARS-CoV-2. The test aims to detect antibodies specific to the coronavirus. The service launch enhanced the company’s portfolio in infectious disease diagnostic services.
Key Companies in the clinical laboratory services market includes.
-
Mayo Medical Laboratories (US)
-
Laboratory Corporation of America Holdings (US)
-
Quest Diagnostics (US)
-
Spectra Laboratories, Inc. (US)
-
Eurofins Scientific (Luxembourg)
-
Sonic Healthcare Limited (Australia)
-
NeoGenomics Laboratories, Inc. (US)
-
Fresenius Medical Care AG & Co. KGaA (Germany)
-
Clinical Reference Laboratory (US)
-
OPKO Health, Inc. (US), among others
Clinical Laboratory Services Industry Developments
January 2021: OPKO Health, Inc. (US), a subsidiary of BioReference Laboratories (US), launched Scarlet Health, an in-home diagnostic service that is fully digitally integrated. This launch helped the company expand its digital health business area.
October 2020: NeoGenomics Laboratories, Inc. (US) partnered with PPD, Inc. (US), and launched a state-of-the-art research laboratory in China. The NeoGenomic expansion helps and local Chinese pharmaceutical companies conduct clinical trials and testing in China.
March 2020: NeoGenomics Laboratories, Inc. (US) entered a three-year agreement with HealthTrust Purchasing Group (HPG) (US), to serve as the cornerstone laboratory for HPG's Specialized Reference Laboratory for Oncology & Cancer Genetics, a newly created category for oncology diagnostics in personalized medicine.
Clinical Laboratory Services Market Segmentation
Clinical Laboratory Services Type Outlook
- Biochemistry
- Endocrinology
- Microbiology
- Hematology
- Histopathology
- Cytology
- Genetic Testing
Clinical Laboratory Services Application Outlook
- Independent Laboratory
- Reference Laboratory
- Hospital Laboratory
Clinical Laboratory Services Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
